Alliancebernstein L.P. Cytokinetics Inc Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Cytokinetics Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,879,161 shares of CYTK stock, worth $98.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,879,161

Previous 1,770,065 6.16%

Holding current value

$98.4 Million

Previous $124 Million 17.96%

% of portfolio

0.04%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $5.22 Million - $8.19 Million	109,096 Added 6.16%	1,879,161 $102 Million
Q1 2024 May 14, 2024	BUY	$63.75 - $108.06 $105 Million - $178 Million	1,647,818 Added 1347.94%	1,770,065 $124 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $213,615 - $663,495	-7,947 Reduced 6.1%	122,247 $10.2 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $1.11 Million - $1.38 Million	-37,729 Reduced 22.47%	130,194 $3.84 Million
Q2 2023 Aug 15, 2023	SELL	$32.62 - $40.75 $1.42 Million - $1.78 Million	-43,574 Reduced 20.6%	167,923 $5.48 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $464,771 - $636,831	-13,932 Reduced 6.18%	211,497 $7.44 Million
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $428,023 - $611,582	-11,966 Reduced 5.04%	225,429 $10.3 Million
Q3 2022 Nov 15, 2022	SELL	$38.54 - $54.52 $2.31 Million - $3.27 Million	-59,915 Reduced 20.15%	237,395 $11.5 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $3.47 Million - $5 Million	102,243 Added 52.41%	297,310 $11.7 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $4.81 Million - $7.45 Million	-161,862 Reduced 45.35%	195,067 $7.18 Million
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $3.64 Million - $4.92 Million	106,047 Added 42.27%	356,929 $16.3 Million
Q3 2021 Nov 10, 2021	SELL	$18.54 - $35.74 $3.81 Million - $7.35 Million	-205,592 Reduced 45.04%	250,882 $8.97 Million
Q2 2021 Jul 30, 2021	BUY	$19.79 - $26.99 $1.86 Million - $2.54 Million	94,150 Added 25.99%	456,474 $9.03 Million
Q1 2021 May 06, 2021	BUY	$18.57 - $25.68 $4.84 Million - $6.7 Million	260,794 Added 256.86%	362,324 $8.43 Million
Q3 2020 Nov 12, 2020	BUY	$20.58 - $28.96 $186,660 - $262,667	9,070 Added 9.81%	101,530 $2.2 Million
Q2 2020 Aug 13, 2020	BUY	$11.15 - $24.64 $276,074 - $610,086	24,760 Added 36.57%	92,460 $2.18 Million
Q1 2020 May 14, 2020	SELL	$8.75 - $16.3 $17,062 - $31,785	-1,950 Reduced 2.8%	67,700 $798,000
Q4 2019 Feb 18, 2020	BUY	$7.95 - $11.84 $20,272 - $30,192	2,550 Added 3.8%	69,650 $739,000
Q3 2019 Nov 14, 2019	SELL	$10.82 - $14.25 $140,660 - $185,250	-13,000 Reduced 16.23%	67,100 $764,000
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $186,825 - $264,375	23,500 Added 41.52%	80,100 $901,000
Q2 2018 Aug 13, 2018	BUY	$6.9 - $9.9 $93,150 - $133,650	13,500 Added 31.32%	56,600 $470,000
Q1 2018 May 14, 2018	SELL	$7.2 - $10.05 $533,304 - $744,403	-74,070 Reduced 63.22%	43,100 $310,000
Q4 2017 Feb 13, 2018	SELL	$7.25 - $15.65 $33,350 - $71,990	-4,600 Reduced 3.78%	117,170 $955,000
Q3 2017 Nov 13, 2017	BUY	$12.0 - $15.0 $1.46 Million - $1.83 Million	121,770	121,770 $1.77 Million

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.93B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Cytokinetics Inc Transaction History